Hasil Pencarian - Christos Vaklavas

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Toward improved models of human cancer

    Toward improved models of human cancer oleh Bryan E. Welm, Christos Vaklavas, Alana L. Welm

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development

    Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development oleh Christos Vaklavas, Scott W. Blume, William E. Grizzle

    Diterbitkan 2017-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer

    Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer oleh Christos Vaklavas, Scott W. Blume, William E. Grizzle

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Erratum: “Toward improved models of human cancer” [APL Bioeng. 5, 010901 (2021)]

    Erratum: “Toward improved models of human cancer” [APL Bioeng. 5, 010901 (2021)] oleh Bryan E. Welm, Christos Vaklavas, Alana L. Welm

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The association between time-of-day of habitual exercise training and changes in relevant cancer health outcomes among cancer survivors.

    The association between time-of-day of habitual exercise training and changes in relevant cancer health outcomes among cancer survivors. oleh Adriana M Coletta, Mary C Playdon, Kelly G Baron, Mei Wei, Kristen Kelley, Christos Vaklavas, Anna Beck, Saundra S Buys, Jonathan Chipman, Cornelia M Ulrich, Darren Walker, Shelley White, Sonal Oza, Rebecca W Zingg, Pamela A Hansen

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome

    A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome oleh John Marsiglio, Jordan P. McPherson, Magdalena Kovacsovics-Bankowski, Joanne Jeter, Christos Vaklavas, Umang Swami, Douglas Grossmann, Alyssa Erickson-Wayman, Heloisa P. Soares, Katie Kerrigan, Berit Gibson, Jennifer Anne Doherty, John Hyngstrom, Sheetal Hardikar, Siwen Hu-Lieskovan

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow

    Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow oleh Jeffrey P. Leal, Steven P. Rowe, Steven P. Rowe, Vered Stearns, Roisin M. Connolly, Christos Vaklavas, Minetta C. Liu, Anna Maria Storniolo, Richard L. Wahl, Martin G. Pomper, Martin G. Pomper, Lilja B. Solnes, Lilja B. Solnes

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

    An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer oleh Erica M. Stringer-Reasor, Jori E. May, Eva Olariu, Valerie Caterinicchia, Yufeng Li, Dongquan Chen, Deborah L. Della Manna, Gabrielle B. Rocque, Christos Vaklavas, Carla I. Falkson, Lisle M. Nabell, Edward P. Acosta, Andres Forero-Torres, Eddy S. Yang

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer

    TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-po... oleh Christos Vaklavas, Brian S. Roberts, Katherine E. Varley, Nancy U. Lin, Minetta C. Liu, Hope S. Rugo, Shannon Puhalla, Rita Nanda, Anna Maria Storniolo, Lisa A. Carey, Mansoor N. Saleh, Yufeng Li, Jennifer F. Delossantos, William E. Grizzle, Albert F. LoBuglio, Richard M. Myers, Andres Forero-Torres, on behalf of the Translational Breast Cancer Research Consortium (TBCRC)

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: